OFER REIZES received the Ph.D. degree in molecular pharmacology from the UT-Southwestern Medical Center, Dallas. He holds a post-doctoral fellowship with the Boston Children's Hospital and the Harvard Medical School. In 2001, he was with Procter & Gamble Pharmaceuticals, Inc., to lead drug discovery efforts in obesity and metabolic diseases, progressing several obesity targets from early discovery to preclinical evaluation. In 2006, he joined the Cleveland Clinic Foundation, where he studies the interface between obesity and cancer. His research has been authored in Cell, the Journal of Clinical Investigation, and the Proceedings of the National Academy of Sciences. He has presented at multiple national and international meetings, including the Endocrine Society and the American Diabetes Association. He has consulted for several biotechnology companies. He is currently a Co-Inventor of a patent titled Methods and Reagents for Regulating Obesity. He is also the Director of Skills Development with the NIH Center for Accelerated Innovations, Cleveland Clinic Foundation.
JTEHM, Articles, Published ArticlesHealthcare Commercialization Programs: Improving the Efficiency of Translating Healthcare Innovations From Academia Into Practice
Academic investigators are generating a plethora of insights and technologies that have the potential to significantly improve patient care. However, to address the imperative to improve the quality, cost and access to care with ever more constrained funding, the efficiency and the... Read more
Posted on 25 OCT 2016